These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

469 related items for PubMed ID: 16843187

  • 1. Blood viscosity and its relationship to iron deficiency, symptoms, and exercise capacity in adults with cyanotic congenital heart disease.
    Broberg CS, Bax BE, Okonko DO, Rampling MW, Bayne S, Harries C, Davidson SJ, Uebing A, Khan AA, Thein S, Gibbs JS, Burman J, Gatzoulis MA.
    J Am Coll Cardiol; 2006 Jul 18; 48(2):356-65. PubMed ID: 16843187
    [Abstract] [Full Text] [Related]

  • 2. Blood is thicker than water: the management of hyperviscosity in adults with cyanotic heart disease.
    DeFilippis AP, Law K, Curtin S, Eckman JR.
    Cardiol Rev; 2007 Jul 18; 15(1):31-4. PubMed ID: 17172881
    [Abstract] [Full Text] [Related]

  • 3. A clinico-hematological study of iron deficiency anemia and its correlation with hyperviscosity symptoms in cyanotic congenital heart disease.
    Gaiha M, Sethi HP, Sudha R, Arora R, Acharya NR.
    Indian Heart J; 1993 Jul 18; 45(1):53-5. PubMed ID: 8365742
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of exercise capacity with cardiopulmonary exercise test and B-type natriuretic peptide in adults with congenital heart disease.
    Trojnarska O, Gwizdała A, Katarzyński S, Katarzyńska A, Szyszka A, Lanocha M, Grajek S, Kramer L.
    Cardiol J; 2009 Jul 18; 16(2):133-41. PubMed ID: 19387960
    [Abstract] [Full Text] [Related]

  • 5. Replacement therapy for iron deficiency improves exercise capacity and quality of life in patients with cyanotic congenital heart disease and/or the Eisenmenger syndrome.
    Tay EL, Peset A, Papaphylactou M, Inuzuka R, Alonso-Gonzalez R, Giannakoulas G, Tzifa A, Goletto S, Broberg C, Dimopoulos K, Gatzoulis MA.
    Int J Cardiol; 2011 Sep 15; 151(3):307-12. PubMed ID: 20580108
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of derived Coulter red blood cell parameters for the assessment of iron deficiency in adults with congenital heart disease.
    Dopsaj V, Mikovic-Golubovic G, Martinovic J, Kalimanovska-Ostric D.
    Int J Lab Hematol; 2012 Oct 15; 34(5):461-72. PubMed ID: 22452801
    [Abstract] [Full Text] [Related]

  • 7. Iron deficiency and hematological changes in adult patients after Fontan operation.
    Tomkiewicz-Pajak L, Plazak W, Kolcz J, Pajak J, Kopec G, Dluzniewska N, Olszowska M, Moryl-Bujakowska A, Podolec P.
    J Cardiol; 2014 Nov 15; 64(5):384-9. PubMed ID: 24698006
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of blood rheology in patients with cyanotic congenital heart disease using a microchannel array flow analyzer.
    Katayama Y, Horigome H, Murakami T, Takahashi-Igari M, Miyata D, Tanaka K.
    Clin Hemorheol Microcirc; 2006 Nov 15; 35(4):499-508. PubMed ID: 17148849
    [Abstract] [Full Text] [Related]

  • 9. Increased blood viscosity in iron-depleted elite athletes.
    Khaled S, Brun JF, Wagner A, Mercier J, Bringer J, Préfaut C.
    Clin Hemorheol Microcirc; 1998 Jul 15; 18(4):309-18. PubMed ID: 9741672
    [Abstract] [Full Text] [Related]

  • 10. Hemorheological correlates of fitness and unfitness in athletes: moving beyond the apparent "paradox of hematocrit"?
    Gaudard A, Varlet-Marie E, Bressolle F, Mercier J, Brun JF.
    Clin Hemorheol Microcirc; 2003 Jul 15; 28(3):161-73. PubMed ID: 12775898
    [Abstract] [Full Text] [Related]

  • 11. Erythrocyte indexes, iron metabolism, and hyperhomocysteinemia in adults with cyanotic congenital cardiac disease.
    Kaemmerer H, Fratz S, Braun SL, Koelling K, Eicken A, Brodherr-Heberlein S, Pietrzik K, Hess J.
    Am J Cardiol; 2004 Sep 15; 94(6):825-8. PubMed ID: 15374802
    [Abstract] [Full Text] [Related]

  • 12. Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial.
    Okonko DO, Grzeslo A, Witkowski T, Mandal AK, Slater RM, Roughton M, Foldes G, Thum T, Majda J, Banasiak W, Missouris CG, Poole-Wilson PA, Anker SD, Ponikowski P.
    J Am Coll Cardiol; 2008 Jan 15; 51(2):103-12. PubMed ID: 18191732
    [Abstract] [Full Text] [Related]

  • 13. The BNP concentrations and exercise capacity assessment with cardiopulmonary stress test in cyanotic adult patients with congenital heart diseases.
    Trojnarska O, Gwizdala A, Katarzynski S, Katarzynska A, Oko-Sarnowska Z, Grajek S, Kramer L.
    Int J Cardiol; 2010 Mar 18; 139(3):241-7. PubMed ID: 19042041
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Whole blood viscosity in beta thalassemia minor.
    Crowley JP, Metzger JB, Merrill EW, Valeri CR.
    Ann Clin Lab Sci; 1992 Mar 18; 22(4):229-35. PubMed ID: 1503390
    [Abstract] [Full Text] [Related]

  • 19. Soluble P-selectin and thrombomodulin-protein C-Protein S pathway in cyanotic congenital heart disease with secondary erythrocytosis.
    Horigome H, Murakami T, Isobe T, Nagasawa T, Matsui A.
    Thromb Res; 2003 Mar 18; 112(4):223-7. PubMed ID: 14987915
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.